1[1]Yuen MF,Hui CK,Cheng CC,et al.Long-term follow-up of interferon-alfa treatment in Chinese patients with chronic hepatitis B infection:the effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complication.Hepatology,2001,34:139-145.
2[2]Honkop P,de Man RA,Niesters HGM,et al.Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy.Hepatology,2000,32:635-640.
3[3]Schlm SW,Heathcote J,Cianciara J,et al.Lamivudine and a-interferon combination treatment of patients with chronic hepatits B infection:a randomized trial.Gut,2000,46:562-568.
4[4]Serfaty LWR,Thabut D,Zoulim F,et al.Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone:results of a pilot study.Hepatology,2001,34:573-577.
5[5]Lau GKK,Tsiang M,Hou J,et al.Combination therapy with lamivudine and famciclovir for chronic hepatitis Binfected Chinese patients:a viral dynamics study.Hepatology,2000,32:394-399.
6[6]Liaw YF,Tsai SL,Chien RN,et al.Prednisolone proming enhances Th 1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis B.Hepatology,2000,32:604-609.
7[7]Blackberg J,Kidd-Ljunggren K.Occult hepatitis B Virus after acute self-limited infection persisting for 30 years without sequence variation.J Hepatology,2000,33:992-997.
8[8]Brechot C,Thiers V,Kremsdorf,et al.Persistent hepatitis B Virus infection in subjects without hepatitis B surface antigen:clincally significant or purely"occult"?Hepatology,2001,34:194-203.
9[9]Prange R,Werr M.DNA-mediated immunization to hepatitis B virus envelop proteins:Pre S antigen secretion enhance the hemoral response.Vaccine,1999,17:617-623.
10[10]Beterams G,Nassal M.Significant interference with hepatitis B Virus replication by a core-nuclease fusion protein.J Biol Chem,2001,276:8875-8883.
